LoginRegister
    USFDA okays female Viagra for treating hypoactive sexual desire disorder in premenopausal womenUSFDA okays female Viagra for treating hypoactive sexual desire disorder in premenopausal women
    MPI beings supplying animal tissue to SCTIMST, medical device industry for making heart valve, wound care patchesMPI beings supplying animal tissue to SCTIMST, medical device industry for making heart valve, wound...
    Fortis Healthcare appoints Sanjay Sinha as Chief of Human Resources OfficerFortis Healthcare appoints Sanjay Sinha as Chief of Human Resources Officer
    India to step up pharmaceutical exports; calls for clear roadmap from ChinaIndia to step up pharmaceutical exports; calls for clear roadmap from China
    GSK eyes sale of $1.2 billion consumer health drugs; says reportGSK eyes sale of $1.2 billion consumer health drugs; says report
    Sun Pharma not following procedures to prevent contamination of drug products; USFDA flags concernSun Pharma not following procedures to prevent contamination of drug products; USFDA flags concern
    Aurobindo Pharma gets USFDA warning letter for Andhra Pradesh unitAurobindo Pharma gets USFDA warning letter for Andhra Pradesh unit
    Sanofi to slash 466 jobs as part of R&D restructureSanofi to slash 466 jobs as part of R&D restructure
    Piramal Pharma invests over Rs 69 crore to expand its API capabilityPiramal Pharma invests over Rs 69 crore to expand its API capability
    Bayer Stivarga becomes first drug to be tested in brain cancer patients in multi-arm cooperation trialBayer Stivarga becomes first drug to be tested in brain cancer patients in multi-arm cooperation...
    Merck CEO sees legal challenge if US adopts drug pricing based on other countriesMerck CEO sees legal challenge if US adopts drug pricing based on other countries
    Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASHZydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar...
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X